Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alacer Sale Underscores Value-Add Of Best Practices

This article was originally published in The Tan Sheet

Executive Summary

Best practices help establish a firm’s appeal as an acquisition target, illustrated by the case of Pfizer’s acquisition of Emergen-C maker Alacer.`

Advertisement

Related Content

Powder/Liquid Delivery Twist: A Consumer-Health Market Shaker?
New Shaker Twist In Delivery Technology Aims To Shake Up Consumer Health Market
New Shaker Twist In Delivery Technology Aims To Shake Up Consumer Health Market
Interview: Fugate Attracted By UrgentRx Focus On Branding, Unique Positioning
Interview: Fugate Attracted By UrgentRx Focus On Branding, Unique Positioning
Supplement AER Under-Reporting Marks Tip Of Compliance Iceberg – FDA
In Brief

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS105742

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel